BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 31793054)

  • 1. Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling.
    Yu J; Chen WX; Xie WJ; Chen RW; Lin DQ; You WW; Ye WL; Zhang HQ; Lin DH; Xu JP
    J Clin Lab Anal; 2021 Aug; 35(8):e23817. PubMed ID: 34114685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin attenuates Adriamycin-resistance of acute myeloid leukemia by inhibiting the lncRNA HOTAIR/miR-20a-5p/WT1 axis.
    Liu JM; Li M; Luo W; Sun HB
    Lab Invest; 2021 Oct; 101(10):1308-1317. PubMed ID: 34282279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. let-7g sensitized liver cancer cells to 5-fluorouracil by downregulating ABCC10 expression.
    Chen Y; Zhang B; Zhong C; Zhou Y; Xue L; Luo C; Yi L; Gong Q; Long Y
    Chem Biol Drug Des; 2024 Jan; 103(1):e14396. PubMed ID: 38054583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pharmacological Strategy Using Stemofoline for more Efficacious Chemotherapeutic Treatments Against Human Multidrug Resistant Leukemic Cells.
    Umsumarng S; Mapoung S; Yodkeeree S; Pyne SG; Limtrakul Dejkriengkraikul P
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3533-3543. PubMed ID: 30583680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HA117 gene increased the multidrug resistance of K562 cells in vitro: an investigation to the function of a novel gene related to drug resistance.
    Guo Y; Zheng G; Jin X; Xu Y; Luo Q; Liu X; Zhao Z; Chen Y
    J Exp Clin Cancer Res; 2009 May; 28(1):63. PubMed ID: 19435509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CADM1 impairs the effect of miR-1246 on promoting cell cycle progression in chemo-resistant leukemia cells.
    Xie B; Zhao L; Zhang Z; Zhou C; Tian Y; Kang Y; Chen J; Wei H; Li L
    BMC Cancer; 2023 Oct; 23(1):955. PubMed ID: 37814227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance.
    Calvani M; Dabraio A; Bruno G; De Gregorio V; Coronnello M; Bogani C; Ciullini S; Marca G; Vignoli M; Chiarugi P; Nardi M; Vannucchi AM; Filippi L; Favre C
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.
    Olesinski EA; Bhatia KS; Wang C; Pioso MS; Lin XX; Mamdouh AM; Ng SX; Sandhu V; Jasdanwala SS; Yilma B; Bohl S; Ryan JA; Malani D; Luskin MR; Kallioniemi O; Porkka K; Adamia S; Chng WJ; Osato M; Weinstock DM; Garcia JS; Letai A; Bhatt S
    Blood Cancer Discov; 2024 May; 5(3):180-201. PubMed ID: 38442309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Polyallylamine Hydrochloride on Gene Expression and Karyotypic Stability of Multidrug Resistant Transformed Cells.
    Alekseenko L; Shilina M; Kozhukharova I; Lyublinskaya O; Fridlyanskaya I; Nikolsky N; Grinchuk T
    Cells; 2020 Oct; 9(10):. PubMed ID: 33096691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Combination of the Total Steroidal Saponins from the Berries of Black Nightshade and Adriamycin to Overcome Leukemia Multidrug Resistance.
    Wang S; Wang L; Xu J; Wang Y; Xiang L; He X
    J Agric Food Chem; 2023 Feb; ():. PubMed ID: 36752041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value analysis of clinical diagnosis of cerebral glioma mRNA let-7f.
    Li Y; Wang G; Yang B; Jian Z; Tang B; Chen G
    Panminerva Med; 2020 Dec; ():. PubMed ID: 33307640
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways.
    Rahmati A; Mafi A; Vakili O; Soleymani F; Alishahi Z; Yahyazadeh S; Gholinezhad Y; Rezaee M; Johnston TP; Sahebkar A
    Ann Hematol; 2024 May; 103(5):1455-1482. PubMed ID: 37526673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel miR-98 Negatively Regulates the Resistance of Endometrial Cancer Cells to Paclitaxel by Suppressing ABCC10/MRP-7.
    Huang W; Zhang J; Dong B; Chen H; Shao L; Li X
    Front Oncol; 2021; 11():809410. PubMed ID: 34950596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3'UTR.
    Johnson DT; Davis AG; Zhou JH; Ball ED; Zhang DE
    Exp Hematol Oncol; 2021 Feb; 10(1):8. PubMed ID: 33531067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA let-7f mediated the Adriamycin resistance in leukemia cell line.
    Cao YX; Wen F; Luo ZY; Long XX; Luo C; Liao P; Li JJ
    J Cell Biochem; 2020 Oct; 121(10):4022-4033. PubMed ID: 31793054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells.
    Zhong J; Zhang J; Yu X; Zhang X; Dian L
    Med Sci Monit; 2020 Aug; 26():e924922. PubMed ID: 32830792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated miR‑130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin.
    Liu H; Liu M; Zhang J; Liang Y
    Mol Med Rep; 2020 Oct; 22(4):2810-2816. PubMed ID: 32945422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.